SA02
** This cell line contains an expected karyotypic abnormality consistent with the phenotype indicated in the "disease" field below. Please see the karyotype report in the Product Information & Testing PDF(s) linked below for more information.Cell Line Alias | SA002, Sahlgrenska 2 |
Cell Type | Human ES |
Disease | Patau Syndrome |
Sex | Female |
Genetically Related Cell Lines | |
Provider | Cellartis/Takara |
dbGaP Data | |
hPSCReg ID | |
NIH Approval | |
Pub Med Abstract | |
Related Products | |
Collection(s) | NIH Approved |
Current Lot Information
Lot Number | Culture Platform | Lot Description | Passage Number | Banked By | Protocol | Product Information & Testing |
---|---|---|---|---|---|---|
DL-01 | Stem Cell Culture Medium (KOSR/MEF) | Trisomy 13 | 35 | WiCell | WiCell Feeder Based (MEF) Pluripotent Stem Cell Protocol |
Historical Lot Information
Lot Number | Culture Platform | Lot Description | Banked By | Protocol | Product Information & Testing |
---|---|---|---|---|---|
CA002 | Stem Cell Culture Medium (KOSR/MEF) | Trisomy 13. | Provider | Cellartis Cell Lines Provider Protocol | |
FTDL-01 | Stem Cell Culture Medium (KOSR/MEF) | Trisomy 13 | WiCell | WiCell Feeder Based (MEF) Pluripotent Stem Cell Protocol | |
MCB-01 | Stem Cell Culture Medium (KOSR/MEF) | Trisonomy 13. Virus testing was completed for this cell line using this lot. | WiCell | WiCell Feeder Based (MEF) Pluripotent Stem Cell Protocol |